Effectiveness of stop-smoking medications: Findings from the International Tobacco Control (ITC) Four Country Survey

Addiction

Volumn 108, Issue 1, 2013, Pages 193-202

  Kasza, Karin A ^a   Hyland, Andrew J ^a   Borland, Ron ^b   McNeill, Ann D ^c   Bansal Travers, Maansi ^a   Fix, Brian V ^a   Hammond, David ^d   Fong, Geoffrey T ^d,e   Cummings, K Michael ^f  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF WATERLOO   (Canada)

^e ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Nicotine replacement therapy; Population effectiveness; Recall bias; Smoking cessation; Stop smoking medication; Varenicline

Indexed keywords

AMFEBUTAMONE; BENZAZEPINE DERIVATIVE; DOPAMINE UPTAKE INHIBITOR; NICOTINE GUM; NICOTINIC AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CANADA; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; SEX RATIO; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AUSTRALIA; BENZAZEPINES; BUPROPION; CANADA; DOPAMINE UPTAKE INHIBITORS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; PROSPECTIVE STUDIES; QUINOXALINES; RECURRENCE; SEX DISTRIBUTION; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84871706885     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04009.x     Document Type: Article

References (48)

1. Silagy C., Lancaster T., Stead L., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; 4: CD000146.
2. Etter J. F., Stapleton J. A. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006; 15 : 280-285.
3. Hughes J. R., Stead L. F., Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; 1: CD000031.
4. Cahill K., Stead L. F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007; 1: CD006103.
5. The tobacco use and dependence clinical practice guideline panel, staff, and consortium representatives. A clinical practice guideline for treating tobacco use and dependence: a US public health service report. JAMA 2000; 283: 3244-3254.
6. West R., McNeill A., Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 2000; 55 : 987-999.
7. Cokkinides V. E., Ward E., Jemal A., Thun J. Under-use of smoking cessation treatments. Am J Prev Med 2005; 28 : 119-122.
8. Cummings K. M., Hyland A. Impact of nicotine replacement therapy on smoking behaviour. Annu Rev Public Health 2005; 26 : 583-599.
9. Mooney M. E., Leventhal A. M., Hatsukami D. K. Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine Tob Res 2006; 8 : 435-446.
10. Pierce J. P., Cummins S. E., White M. M., Humphrey A., Messer K. Quitlines and nicotine replacement for smoking cessation: do we need to change policy? Annu Rev Public Health 2012; 33 : 341-356.
11. Zhu S.-H., Lee M., Zhuang Y.-L., Gamst A., Wolfson T. Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob Control 2012; 21 : 110-118.
12. Cooper J., Borland R., Yong H. H. Australian smokers increasingly use help to quit, but number of attempts remains stable: findings from the International Tobacco Control study 2002-2009. Aust NZ J Public Health 2011; 35 : 368-376.
13. Fix B. V., Hyland A., Rivard C., McNeill A., Fong G. T., Borland R. etal. Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health 2011; 8 : 222-233.
14. Le Strat Y., Rehm J., Le Foll B. How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control 2011; 20 : 338-343.
15. Hughes J. R., Peters E. N., Naud S. Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials. Nicotine Tob Res 2011; 13 : 512-522.
16. Walsh R. A. Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness. Drug Alcohol Rev 2008; 27 : 529-547.
17. Pierce J. P., Gilpin E. A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002; 288 : 1260-1264.
18. Hyland A., Rezaishiraz A., Giovino G., Bauer J. E., Cummings K. M. Over-the-counter availability of nicotine replacement therapy and smoking cessation. Nicotine Tob Res 2005; 7 : 547-555.
19. Thorndike A. N., Biener L., Rigotti N. A. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2002; 92 : 437-442.
20. Shiffman S., Brockwell S. E., Pillitteri J. L., Gitchell J. G. Use of smoking-cessation treatments in the United States. Am J Prev Med 2008; 34 : 102-111.
21. Alberg A. J., Patnaik J. L., May J. W., Hoffman S. C., Gitchell J., Helzlsouer K. J. Nicotine replacement therapy use among a cohort of smokers. J Addict Dis 2005; 24 : 101-103.
22. Alpert H. R., Connolly G. N., Biener L. A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control 2012; doi:10.1136/tobaccocontrol-2011-050129.
23. West R., Zhou X. Is nicotine replacement therapy for smoking cessation effective in the 'real world'? Findings from a prospective multinational cohort study. Thorax 2007; 62 : 998-1002.
24. Cummings K. M., Fix B., Celestino P., Carlin-Menter S., O'Connor R., Hyland A. Reach, efficacy, and cost-effectiveness of free nicotine medication giveaway programs. J Public Health Manag Pract 2006; 12 : 37-43.
25. Miller M., Frieden T. R., Liu S. Y., Matte T. D., Mostashari F., Deitcher D. R. etal. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 2005; 365 : 1849-1854.
26. Gilpin E. A., Messer K., Pierce J. P. Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success? Nicotine Tob Res 2006; 8 : 661-669.
27. Kotz D., Fidler J. A., West R. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications? Nicotine Tob Res 2011; 13 : 793-799.
28. West R., DiMarino M. E., Gitchell J., McNeill A. Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control 2005; 14 : 166-171.
29. Chapman S. Smoking cessation: big pharma butts in. BMJ 2011; 343 : 344-345.
30. Shiffman S., Di Marino M. E., Sweeney C. T. Characteristics of selectors of nicotine replacement therapy. Tob Control 2005; 14 : 346-355.
31. Kotz D., Fidler J., West R. Factors associated with the use of aids to cessation in English smokers. Addiction 2009; 104 : 1403-1410.
32. Bansal M. A., Cummings K. M., Hyland A., Giovino G. A. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res 2004; 6 : S303-310.
33. Berg C. J., An L. C., Kirch M., Guo H., Thomas J. L., Patten C. A. etal. Failure to report attempts to quit smoking. Addict Behav 2010; 35 : 900-904.
34. Borland R., Partos T. R., Young H.-H., Cummings K. M., Hyland A. How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction 2012; 107 : 673-682.
35. Gilpin E., Pierce J. P. Measuring smoking cessation: problems with recall in the 1990 California Tobacco Survey. Cancer Epidemiol Biomarkers Prev 1994; 3 : 613-617.
36. Borland R., Partos T. R., Cummings K. M. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res 2012; doi: 10.1093/ntr/nts002.
37. Fong G. T., Cummings K. M., Borland R., Hastings G., Hyland A. J., Giovino G. A. etal. The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control 2006; 15 : iii3-11.
38. Hammond D., Fong G. T., Thompson M. E., Driezen P. International Tobacco Control Policy Evaluation Survey (ITC 4-Country Survey) Wave 1 Technical Report . 2004. Available at: http://www.itcproject.org/documents/keyfindings/technicalreports/itcw1techreportfinalpdf. (accessed 17 February 2012) (Archived by WebCite® at http://www.webcitation.org/65WlnsWWy).
39. Fong G. T., Thompson M., Hammond D., Boudreau C., Driezen P. International Tobacco Control Policy Evaluation Survey (ITC), Four Country Project, Waves 2-8 Technical Report . 2011. Available at: http://www.itcproject.org/documents/keyfindings/4cw28techreportmay2011_2_pdf (accessed 17 February 2012) (Archived by WebCite® at http://www.webcitation.org/65WmeqN1E).
40. Thompson M. E., Fong G. T., Hammond D., Boudreau C., Driezen P., Hyland A. etal. Methods of the International Tobacco Control (ITC) Four Country Survey. Tob Control 2006; 15 : iii12-18.
41. International Tobacco Control Policy Evaluation Project. 4-Country Survey Questionnaires. 2009-2011. Available at: http://www.itcproject.org/ (accessed 17 February 2012) (Archived by WebCite® at http://www.webcitation.org/65Wm59nLc).
42. Heatherton T. F., Kozlowski L. T., Frecker R. C., Rickert W., Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84 : 791-800.
43. StataCorp . STATA Statistical Software, version 11. College Station, TX: StataCorp LP; 2009.
44. Liang K. Y., Zeger S. L. Longitudinal data using generalized linear models. Biometrika 1986; 73 : 13-22.
45. Hardin J. W., Hilbe J. M. Generalized Estimating Equations. Boca Raton, FL: Chapman & Hall/CRC; 2003.
46. GlaxoSmithKline. Product information, Nicorette Gum . 2012. Available at: http://www.nicorette.com/quit-smoking-products/nicorette-gum.aspx (accessed 17 February 2012) (Archived by WebCite® at http://www.webcitation.org/65WmEyVgE).
47. Shiffman S., Ferguson S. G., Rohay J., Gitchell J. G. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction 2008; 103 : 1371-1378.
48. Etter J.-F., Schneider N. G. An Internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion. Nicotine Tob Res 2012; doi: 10.1093/ntr/nts084.